Background Mortality rates of coronavirus disease-2019 (COVID-19) continue to rise across
the world. The impact of several risk factors on coronavirus mortality has been previously …

Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

Children and adolescents exhibit a broad range of clinical outcomes from SARS-CoV-2
infection, with the majority having minimal to mild symptoms. Additionally, some succumb to …

The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Background Post‐COVID‐19 symptoms and diseases appeared on many survivors from
COVID‐19 which are similar to that of the post‐severe acute respiratory syndrome (SARS) …

Summary The coronavirus disease 2019 (COVID‐19) pandemic is a rapidly evolving global
emergency that continues to strain healthcare systems. Emerging research describes a …

Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …

Since the initial COVID-19 outbreak in China, much attention has focused on people with
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …

Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …

Background and purpose The objective of our systematic review is to identify prognostic
factors that may be used in decision-making related to the care of patients infected with …